| Novartis AG. (11/21/24). "Press Release: Addressing Unmet Needs for Inherited Neuromuscular Diseases. Novartis Has Acquired Kate Therapeutics to Further Enhance and Strengthen Our Ongoing Efforts to Advance Gene Therapies for Patients". |
2024-11-21 |
| Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA. |
2024-11-20 |
| Infrareal Holding GmbH & Co. KG. (11/20/24). "Press Release: Infrareal Takes Over Pharmaceutical and Biotech Site in Orth, Lower Austria". Gütersloh. |
2024-11-20 |
| Glox Therapeutics Ltd.. (11/20/24). "Press Release: Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens". Glasgow. |
2024-11-20 |
| Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge. |
2024-11-20 |
| Halozyme Therapeutics, Inc.. (11/18/24). "Press Release: Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec". San Diego, CA. |
2024-11-18 |
| CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. |
2024-11-14 |
| Halozyme Therapeutics, Inc.. (11/14/24). "Press Release: Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction". San Diego, CA. |
2024-11-14 |
| Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
| Andera Partners. (11/13/24). "Press Release: Andera Partners Continues Its International Expansion and Announces the Opening of a Madrid Office". Paris & Madrid. |
2024-11-13 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
| VarmX B.V.. (11/12/24). "Press Release: VarmX Announces Appointment of John Glasspool as CEO". Leiden. |
2024-11-12 |
| Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz. |
2024-11-12 |
| High-Tech Gründerfonds Management GmbH. (11/12/24). "Press Release: Zymofix Secures €2 Million to Scale Microbial Solutions for Sustainable Agriculture and Beyond". Ghent. |
2024-11-12 |
| Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
| Mediaire GmbH. (11/12/24). "Press Release: Mediaire Transforms Radiology with AI, Securing a European €12 Million Investment to Fuel Global Growth". |
2024-11-12 |
| Vilnius University. (11/11/24). "Press Release: Vilnius University Researchers Uncover New Gene Silencing Mechanism". |
2024-11-11 |
| Biocat. (11/7/24). "Press Release: Barcelona to Host BioSpain in 2025 and 2027". Madrid & Barcelona. |
2024-11-07 |
| Bertelsmann Investments. (11/7/24). "Press Release: Bertelsmann Investments Makes Further Investments in Fast-growing Digital Health Market". Gütersloh. |
2024-11-07 |
| CRISPR Therapeutics AG. (11/7/24). "Press Release: CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference". Zug & Boston, MA. |
2024-11-07 |
| CRISPR Therapeutics AG. (11/5/24). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results". Zug & Boston, MA. |
2024-11-05 |
| BioSpring GmbH. (11/5/24). "Press Release: BioSpring Has Been Granted Manufacturing Authorization (ICH Q7) for cGMP-grade mRNA Production from the German Authorities". Frankfurt a. M.. |
2024-11-05 |
| Rock Capital Group. (11/5/24). "Press Release: Praimera Biotech AG Rents 600 m² of Lab Office Space at Skygate in Hallbergmoos near Munich". Munich-Hallbergmoos. |
2024-11-05 |
| PrognomiQ. (11/5/24). "Press Release: PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform". San Mateo, CA. |
2024-11-05 |
| High-Tech Gründerfonds Management GmbH. (10/31/24). "Press Release: Berlin-Based Neurotech Startup Nuuron Secures Investment for the Development of a Digital Drug to Treat Alzheimer’s Disease". |
2024-10-31 |
| Kynos Therapeutics Ltd.. (10/29/24). "Press Release: Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio". Freiburg. |
2024-10-29 |
| Aignostics GmbH. (10/29/24). "Press Release: Aignostics Secures $34M Series B to Enhance Precision Medicine with AI". Berlin & New York, NY. |
2024-10-29 |
| Valanx Biotech GmbH. (10/29/24). "Press Release: Valanx Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development". Klosterneuburg & Rockville, MD. |
2024-10-29 |
| Biotest AG. (10/29/24). "Press Release: Biotest and SteinCares Partner to Improve Access to Plasma-derived Products in Latin America". Dreieich. |
2024-10-29 |
| Inbrain Neuroelectronics S.L.. (10/29/24). "Press Release: Inbrain Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology". Barcelona. |
2024-10-29 |
| Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
| Ottimo Pharma Ltd.. (10/28/24). "Press Release: Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 20 |
2024-10-28 |
| Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne. |
2024-10-25 |
| AbbVie Inc.. (10/24/24). "Press Release: AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions". North Chicago, IL & Budapest. |
2024-10-24 |
| ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London. |
2024-10-22 |
| |transkript [Kääb, Georg]. (10/21/24). "Miltenyi Biotec: An Exclusive, Rare Interview with Founder Stefan Miltenyi. Interview by |transkript.de/Georg Kääb". |
2024-10-21 |
| UpNano GmbH. (10/17/24). "Press Release: Industry Groups Invest in High Performance 2PP 3D Print Technology". Vienna. |
2024-10-17 |
| BenevolentAI Ltd.. (10/17/24). "Press Release: BenevolentAI Appoints Kenneth Mulvany as Executive Chairman". London. |
2024-10-17 |
| Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing
> Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA. |
2024-10-16 |
| Shift Bioscience Ltd.. (10/15/24). "Press Release: Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform". Cambridge. |
2024-10-15 |
| Forbion Capital Partners. (10/15/24). "Press Release: Forbion Raises in Excess of €2 Billion for Two New Funds". Naarden. |
2024-10-15 |
| Antiverse Ltd.. (10/15/24). "Press Release: Antiverse Raises £3.5M ($4.6M) to Advance Generative AI Antibody Design Platform". Cardiff. |
2024-10-15 |
| Invios GmbH. (10/15/24). "Press Release: Invios Raises €8.2 Million in a Series A to Finance Pipeline Progress in Immuno-oncology". Vienna. |
2024-10-15 |
| Innate Pharma S.A.. (10/14/24). "Press Release: Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board". |
2024-10-14 |
| H. Lundbeck A/S. (10/14/24). "Press Release: Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline". Valby & La Jolla, CA. |
2024-10-14 |
| Cosmo Pharmaceuticals N.V.. (10/11/24). "Press Release: Cosmo Pharmaceuticals Appoints New Chief Financial Officer". Dublin. |
2024-10-11 |
| Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Updated Phase 1b Clinical Data on ACTengine IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial". Houston, TX & Tübingen. |
2024-10-10 |
| Camp4 Therapeutics Corporation. (10/10/24). "Press Release: Camp4 Announces Pricing of Initial Public Offering". Cambridge, MA. |
2024-10-10 |
| Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin. |
2024-10-10 |
| Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Proposed $150 Million Public Offering". Houston, TX & Tübingen. |
2024-10-10 |
| Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer". |
2024-10-10 |
| Clock Bio Ltd.. (10/9/24). "Press Release: clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors". Cambridge. |
2024-10-09 |
| Boehringer Ingelheim. (10/9/24). "Press Release: Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment". Ingelheim & South San Francisco, CA. |
2024-10-09 |
| a:head bio AG. (10/9/24). "Press Release: a:head Secures Pre-Series A Funding and Appoints Margarete Schramboeck and Madeline Lancaster to the Supervisory Board". Vienna. |
2024-10-09 |
| SphingoTec GmbH. (10/9/24). "Press Release: Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care". Hennigsdorf. |
2024-10-09 |
| Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London. |
2024-10-09 |
| Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
| Lymphatica Medtech S.A.. (10/8/24). "Press Release: Lymphatica Medtech Closes €17.9m Series B Funding Round to Drive Innovation in Lymphedema Treatment". Lausanne. |
2024-10-08 |
| Somagenetix AG. (10/8/24). "Press Release: Somagenetix AG Secures CHF 10 Million in Series A Financing to Advance Lentiviral Gene Therapy for Chronic Granulomatous Disease (CGD)". Zurich. |
2024-10-08 |
| Yumab GmbH. (10/8/24). "Press Release: Yumab and Molcure Collaborate To Advance Zero-Shot AI Antibody Discovery Technology For Undrugged Targets". |
2024-10-08 |
| Eversana. (10/7/24). "Press Release: Eversana Expands Global Commercialisation Operations With Berlin, Germany Office". Berlin. |
2024-10-07 |
| CrestOptics S.p.A.. (10/7/24). "Press Release: CrestOptics and Leica Microsystems Announce Strategic Collaboration to Expand Capabilities of Spinning Disk Microscopy". Rome. |
2024-10-07 |
| Mérieux NutriSciences Corporation. (10/7/24). "Press Release: Mérieux NutriSciences Enters Agreement to Acquire Worldwide Food Testing Business of Bureau Veritas". Chicago, IL. |
2024-10-07 |
| Ten23 Health AG. (10/7/24). "Press Release: BD and Ten23 Health Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-enabled Prefillable Syringes". Franklin Lakes, NJ & Basel. |
2024-10-07 |
| Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford. |
2024-10-03 |
| Kurma Partners. (10/3/24). "Press Release: Kurma Partners Achieves First Close of New EUR 250 Million Biofund IV". Paris. |
2024-10-03 |
| Ferring Pharmaceuticals S.A.. (10/3/24). "Press Release: Ferring Bolsters Global Gene Therapy Supply Chain with European Manufacturing Facility". Saint-Prex. |
2024-10-03 |
| LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge. |
2024-10-02 |
| Bruker Corporation. (10/2/24). "Press Release: Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery". Munich. |
2024-10-02 |
| Aitiologic GmbH. (10/1/24). "Press Release: Aitiologic Emerges from Stealth Mode with over €2.5M in Funding to Advance AI-powered Liquid Biopsy Platform for Early Disease Detection". Vienna. |
2024-10-01 |
| 1BillionLives GmbH (d/b/a Flinn). (9/30/24). "Press Release: Flinn.ai Secures 10 Million Euros in Less than 18 Months". |
2024-09-30 |
| Regor Pharmaceuticals (USA). (9/30/24). "Press Release: Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of Next-generation CDK Inhibitors for the Treatment of Breast Cancer". Cambridge, MA. |
2024-09-30 |
| Sequentia Biotech S.L.. (9/27/24). "Press Release: Sequentia Biotech Secures €10 Million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications". Barcelona. |
2024-09-27 |
| Evotec SE. (9/26/24). "Press Release: Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-generation Cell Therapies". Hamburg. |
2024-09-26 |
| Flash Therapeutics SAS (c/b/a Flash BioSolutions). (9/25/24). "Press Release: Flash BioSolutions Launches GMP Production of Revolutionary mRNA Technology for Next-generation Vaccines and Therapies". Toulouse. |
2024-09-25 |
| Genespire S.r.l.. (9/25/24). "Press Release: Genespire Raises €46.6 Million (~$52 Million) in a Series B Round to Advance Its First Pediatric in-vivo Gene Therapy into the Clinic". Milan. |
2024-09-25 |
| Aptadir Therapeutics. (9/24/24). "Press Release: Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors". Milan. |
2024-09-24 |
| Constructive Biology Ltd.. (9/24/24). "Press Release: Constructive Bio Secures $58 Million in Series A Financing". Cambridge. |
2024-09-24 |
| Lift BioSciences Ltd.. (9/24/24). "Press Release: Lift BioSciences Raises £10m in First Close of Series A to Advance First-in-Class Allogeneic Innate Cell Therapy". Milan. |
2024-09-24 |
| Generative:Biomedicines. (9/24/24). "Press Release: Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI". Somerville, MA. |
2024-09-24 |
| Minaris Regnerative Medicine GmbH. (9/24/24). "Press Release: Minaris Regenerative Medicine Announces Agreement to be Acquired by Altaris". Yokohama, Munich & Allendale, NJ. |
2024-09-24 |
| |transkript [Kääb, Georg]. (9/24/24). "First German Life Sciences IPO since 2016 – Radiopharma Company Pentixapharm Lists at Frankfurt Stock Exchange. Interview by |transkript.de/Georg Kääb with Andreas Eckert". |
2024-09-24 |
| Resonac Corporation. (9/24/24). "Press Release: Resonac Corporation Signs Contract to Transfer Shares of Minaris Regenerative Medicine Subsidiaries to Altaris". Zwingenberg. |
2024-09-24 |
| Pentixapharm Holding AG. (9/23/24). "Press Release: Pentixapharm Holding AG Sets Price Range for Planned IPO [Not for US, AU, CA, JP, ZA, et al.]". Berlin & Würzburg. |
2024-09-23 |
| Cosmo Pharmaceuticals N.V.. (9/23/24). "Press Release: Cosmo Pharmaceuticals Enhances Management Team with Newly Appointed Head of Global Business Development". Dublin. |
2024-09-23 |
| BRAIN Biotech AG. (9/20/24). "Press Release: BRAIN Biotech AG Concludes Major Pharma Compound Transaction Valued up to EUR 128.88 Million from Its BioIncubator". Zwingenberg. |
2024-09-20 |
| Symrise AG. (9/20/24). "Press Release: Symrise and Shan Foods Inaugurate a State-of-the-Art International Standard Production Facility for Its Strategic Partnership in Pakistan". Dubai, Holzminden & Karachi. |
2024-09-20 |
| Messe München GmbH. (9/19/24). "Press Release: Analytica Expands Its International Network to the USA. Analytica USA Celebrates Its Premiere in Columbus, Ohio in September 2025". Munich. |
2024-09-19 |
| Eleva GmbH. (9/19/24). "Press Release: Eleva Appoints Dr. Elisabeth Lackner to Its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization". Freiburg im Breisgau. |
2024-09-19 |
| Nagi Bioscience S.A.. (9/19/24). "Press Release: Nagi Bioscience Launches Exclusive Priority Access Program, Bringing Revolutionary SydLab One Platform to Five Leading academic Labs for C. elegans Research". Saint-Sulpice. |
2024-09-19 |
| Noah Labs GmbH. (9/19/24). "Press Release: Noah Labs Receives €3 Million in Financing Round Led by Nina Capital". Berlin & Potsdam. |
2024-09-19 |
| Halix B.V.. (9/19/24). "Press Release: Halix Appoints Dr. Lutz Hilbrich as New Chief Executive Officer". Leiden. |
2024-09-19 |
| Qiagen N.V.. (9/18/24). "Press Release: Qiagen Expands QIAcuity Digital PCR Offering with over New 100 Assays via GeneGlobe Platform". Venlo. |
2024-09-18 |
| Organon & Co.. (9/18/24). "Press Release: Organon to Acquire Dermavant including Its Innovative Dermatologic Therapy, Vtama (tapinarof) Cream, 1%". Jersey City, NJ. |
2024-09-18 |
| Boehringer Ingelheim Stiftung / ÖAW. (9/18/24). "Press Release: OeAW and Boehringer Ingelheim Foundation Establish New Institute for Biomedical Artificial Intelligence in Vienna". Mainz. |
2024-09-18 |
| NanoVation Therapeutics Inc.. (9/18/24). "Press Release: NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases". Vancouver, BC. |
2024-09-18 |
| Oribiotech Ltd.. (9/18/24). "Press Release: Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing". Philadeliphia, PA. |
2024-09-18 |
| Subject Well, Inc. (SubjectWell). (9/17/24). "Press Release: SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities". |
2024-09-17 |
| ImmunOs Therapeutics AG. (9/17/24). "Press Release: ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base". |
2024-09-17 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 ... 67 68 69 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
